Villa LL

ORCID: 0000-0003-4074-2335 · 1 paper in corpus

2008

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.

Vaccine ·doi:10.1016/j.vaccine.2008.06.002

This review focuses on recent publications of clinical trials of two prophylactic human papillomavirus (HPV) vaccines: Gardasil (Merck & Co., Inc., Whitehouse Station, NJ USA), a quadrivalent vaccine containing L1 virus-like particles (VLPs…